{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T12:56:29Z","timestamp":1793537789571,"version":"4.5.0"},"reference-count":158,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,6,29]],"date-time":"2020-06-29T00:00:00Z","timestamp":1593388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2020,6,29]],"date-time":"2020-06-29T00:00:00Z","timestamp":1593388800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Metastasis Rev"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1007\/s10555-020-09909-3","type":"journal-article","created":{"date-parts":[[2020,6,29]],"date-time":"2020-06-29T04:02:36Z","timestamp":1593403356000},"page":"783-803","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":587,"title":["The role of fibroblast activation protein in health and malignancy"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2814-0481","authenticated-orcid":false,"given":"Allison A.","family":"Fitzgerald","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5192-0710","authenticated-orcid":false,"given":"Louis M.","family":"Weiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,29]]},"reference":[{"key":"9909_CR1","doi-asserted-by":"publisher","first-page":"8296","DOI":"10.1073\/pnas.87.21.8296","volume":"87","author":"A Aoyama","year":"1990","unstructured":"Aoyama, A., & Chen, W. T. (1990). A 170-kDa membrane-bound protease is associated with the expression of invasiveness by human malignant melanoma cells. Proc Natl Acad Sci U S A, 87, 8296\u20138300.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9909_CR2","first-page":"5702","volume":"54","author":"WL Monsky","year":"1994","unstructured":"Monsky, W. L., Lin, C. Y., Aoyama, A., Kelly, T., Akiyama, S. K., Mueller, S. C., & Chen, W. T. (1994). A potential marker protease of invasiveness, seprase, is localized on invadopodia of human malignant melanoma cells. Cancer Res, 54, 5702\u20135710.","journal-title":"Cancer Res"},{"key":"9909_CR3","doi-asserted-by":"publisher","first-page":"7595","DOI":"10.1074\/JBC.272.12.7595","volume":"272","author":"ML Pi\u00f1eiro-S\u00e1nchez","year":"1997","unstructured":"Pi\u00f1eiro-S\u00e1nchez, M. L., Goldstein, L. A., Dodt, J., et al. (1997). Identification of the 170-kDa melanoma membrane-bound gelatinase (seprase) as a serine integral membrane protease. J Biol Chem, 272, 7595\u20137601. https:\/\/doi.org\/10.1074\/JBC.272.12.7595.","journal-title":"J Biol Chem"},{"key":"9909_CR4","doi-asserted-by":"publisher","unstructured":"Mathew, S., Scanlan, M.J., Mohan Raj, B.K., et al (1995) The gene for fibroblast activation protein \u03b1 (FAP), a putative cell surface-bound serine protease expressed in cancer stroma and wound healing, maps to chromosome band 2q23. Genomics 25:335\u2013337. https:\/\/doi.org\/10.1016\/0888-7543(95)80157-H","DOI":"10.1016\/0888-7543"},{"key":"9909_CR5","doi-asserted-by":"publisher","unstructured":"Iwasa, S., Jin, X., Okada, K., et al (2003) Increased expression of seprase, a membrane-type serine protease, is associated with lymph node metastasis in human colorectal cancer. Cancer Lett 199:91\u201398. https:\/\/doi.org\/10.1016\/S0304-3835(03)00315-X","DOI":"10.1016\/S0304-3835"},{"key":"9909_CR6","first-page":"855","volume":"11","author":"T Kelly","year":"1998","unstructured":"Kelly, T., Kechelava, S., Rozypal, T. L., et al. (1998). Seprase, a membrane-bound protease, is overexpressed by invasive ductal carcinoma cells of human breast cancers. Mod Pathol, 11, 855\u2013863.","journal-title":"Mod Pathol"},{"key":"9909_CR7","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1159\/000082926","volume":"67","author":"Y Mori","year":"2004","unstructured":"Mori, Y., Kono, K., Matsumoto, Y., et al. (2004). The expression of a type II transmembrane serine protease (Seprase) in human gastric carcinoma. Oncology, 67, 411\u2013419. https:\/\/doi.org\/10.1159\/000082926.","journal-title":"Oncology"},{"key":"9909_CR8","doi-asserted-by":"crossref","unstructured":"Lo, A., Li, C.-P., Buza, E. L., et al. (2017). Fibroblast activation protein augments progression and metastasis of pancreatic ductal adenocarcinoma. J Clin Invest, 2.","DOI":"10.1172\/jci.insight.92232"},{"key":"9909_CR9","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1158\/2326-6066.CIR-13-0150","volume":"2","author":"JN Arnold","year":"2014","unstructured":"Arnold, J. N., Magiera, L., Kraman, M., & Fearon, D. T. (2014). Tumoral immune suppression by macrophages expressing fibroblast activation protein-\u03b1 and heme oxygenase-1. Cancer Immunol Res, 2, 121\u2013126. https:\/\/doi.org\/10.1158\/2326-6066.CIR-13-0150.","journal-title":"Cancer Immunol Res"},{"key":"9909_CR10","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1182\/blood-2005-08-3452","volume":"107","author":"KN Lee","year":"2006","unstructured":"Lee, K. N., Jackson, K. W., Christiansen, V. J., et al. (2006). Antiplasmin-cleaving enzyme is a soluble form of fibroblast activation protein. Blood, 107, 1397\u20131404. https:\/\/doi.org\/10.1182\/blood-2005-08-3452.","journal-title":"Blood"},{"key":"9909_CR11","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S0925-4439(97)00032-X","volume":"1361","author":"LA Goldstein","year":"1997","unstructured":"Goldstein, L. A., Ghersi, G., Pineiro-Sanchez, M. L., et al. (1997). Molecular cloning of seprase: a serine integral membrane protease from human melanoma. Biochim Biophys Acta, 1361, 11\u201319.","journal-title":"Biochim Biophys Acta"},{"key":"9909_CR12","doi-asserted-by":"publisher","unstructured":"Rosenblum, J.S., Kozarich, J.W. (2003) Prolyl peptidases: A serine protease subfamily with high potential for drug discovery. Curr Opin Chem Biol 7:496\u2013504. https:\/\/doi.org\/10.1016\/S1367-5931(03)00084-X","DOI":"10.1016\/S1367-5931"},{"key":"9909_CR13","doi-asserted-by":"publisher","first-page":"2320","DOI":"10.1016\/J.BIOCEL.2004.05.006","volume":"36","author":"PJ Collins","year":"2004","unstructured":"Collins, P. J., McMahon, G., O\u2019Brien, P., & O\u2019Connor, B. (2004). Purification, identification and characterisation of seprase from bovine serum. Int J Biochem Cell Biol, 36, 2320\u20132333. https:\/\/doi.org\/10.1016\/J.BIOCEL.2004.05.006.","journal-title":"Int J Biochem Cell Biol"},{"key":"9909_CR14","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1016\/j.febslet.2006.01.087","volume":"580","author":"CY Edosada","year":"2006","unstructured":"Edosada, C. Y., Quan, C., Tran, T., et al. (2006). Peptide substrate profiling defines fibroblast activation protein as an endopeptidase of strict Gly 2 -Pro 1 -cleaving specificity. FEBS Lett, 580, 1581\u20131586. https:\/\/doi.org\/10.1016\/j.febslet.2006.01.087.","journal-title":"FEBS Lett"},{"key":"9909_CR15","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1021\/bi701921b","volume":"47","author":"S Aggarwal","year":"2008","unstructured":"Aggarwal, S., Brennen, W. N., Kole, T. P., Schneider, E., Topaloglu, O., Yates, M., Cotter, R. J., & Denmeade, S. R. (2008). Fibroblast activation protein peptide substrates identified from human collagen I derived gelatin cleavage sites. Biochemistry, 47, 1076\u20131086. https:\/\/doi.org\/10.1021\/bi701921b.","journal-title":"Biochemistry"},{"key":"9909_CR16","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1093\/jb\/mvr017","volume":"149","author":"C-H Huang","year":"2011","unstructured":"Huang, C.-H., Suen, C.-S., Lin, C.-T., et al. (2011). Cleavage-site specificity of prolyl endopeptidase FAP investigated with a full-length protein substrate. J Biochem, 149, 685\u2013692. https:\/\/doi.org\/10.1093\/jb\/mvr017.","journal-title":"J Biochem"},{"key":"9909_CR17","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1111\/j.1742-4658.2011.08051.x","volume":"278","author":"FM Keane","year":"2011","unstructured":"Keane, F. M., Nadvi, N. A., Yao, T.-W., & Gorrell, M. D. (2011). Neuropeptide\u2003Y, B-type natriuretic peptide, substance\u2003P and peptide\u2003YY are novel substrates of fibroblast activation protein-\u03b1. FEBS J, 278, 1316\u20131332. https:\/\/doi.org\/10.1111\/j.1742-4658.2011.08051.x.","journal-title":"FEBS J"},{"key":"9909_CR18","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.abb.2006.11.006","volume":"457","author":"VJ Christiansen","year":"2007","unstructured":"Christiansen, V. J., Jackson, K. W., Lee, K. N., & McKee, P. A. (2007). Effect of fibroblast activation protein and alpha2-antiplasmin cleaving enzyme on collagen types I, III, and IV. Arch Biochem Biophys, 457, 177\u2013186. https:\/\/doi.org\/10.1016\/j.abb.2006.11.006.","journal-title":"Arch Biochem Biophys"},{"key":"9909_CR19","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1002\/hep.510290631","volume":"29","author":"MT Levy","year":"1999","unstructured":"Levy, M. T., McCaughan, G. W., Abbott, C. A., Park, J. E., Cunningham, A. M., M\u00fcller, E., Rettig, W. J., & Gorrell, M. D. (1999). Fibroblast activation protein: A cell surface dipeptidyl peptidase and gelatinase expressed by stellate cells at the tissue remodelling interface in human cirrhosis. Hepatology, 29, 1768\u20131778. https:\/\/doi.org\/10.1002\/hep.510290631.","journal-title":"Hepatology"},{"key":"9909_CR20","doi-asserted-by":"publisher","first-page":"5986","DOI":"10.1074\/jbc.M115.710582","volume":"291","author":"DR Dunshee","year":"2016","unstructured":"Dunshee, D. R., Bainbridge, T. W., Kljavin, N. M., et al. (2016). Fibroblast activation protein cleaves and inactivates fibroblast growth factor 21. J Biol Chem, 291, 5986\u20135996. https:\/\/doi.org\/10.1074\/jbc.M115.710582.","journal-title":"J Biol Chem"},{"key":"9909_CR21","doi-asserted-by":"publisher","first-page":"3783","DOI":"10.1182\/blood-2003-12-4240","volume":"103","author":"KN Lee","year":"2004","unstructured":"Lee, K. N., Jackson, K. W., Christiansen, V. J., et al. (2004). A novel plasma proteinase potentiates alpha2-antiplasmin inhibition of fibrin digestion. Blood, 103, 3783\u20133788. https:\/\/doi.org\/10.1182\/blood-2003-12-4240.","journal-title":"Blood"},{"key":"9909_CR22","doi-asserted-by":"publisher","unstructured":"Ramirez-Montagut, T., Blachere, N.E., Sviderskaya, E. V, et al (2004) FAP\u03b1, a surface peptidase expressed during wound healing, is a tumor suppressor. Oncogene 23:5435\u20135446. https:\/\/doi.org\/10.1038\/sj.onc.1207730","DOI":"10.1038\/sj.onc.1207730"},{"key":"9909_CR23","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s10585-011-9392-x","volume":"28","author":"Y Huang","year":"2011","unstructured":"Huang, Y., Simms, A. E., Mazur, A., et al. (2011). Fibroblast activation protein-\u03b1 promotes tumor growth and invasion of breast cancer cells through non-enzymatic functions. Clin Exp Metastasis, 28, 567\u2013579. https:\/\/doi.org\/10.1007\/s10585-011-9392-x.","journal-title":"Clin Exp Metastasis"},{"key":"9909_CR24","first-page":"201","volume":"13","author":"B Lv","year":"2016","unstructured":"Lv, B., Xie, F., Zhao, P., et al. (2016). Promotion of cellular growth and motility is independent of enzymatic activity of fibroblast activation protein-\u03b1. Cancer Genomics Proteomics, 13, 201\u2013208.","journal-title":"Cancer Genomics Proteomics"},{"key":"9909_CR25","doi-asserted-by":"publisher","first-page":"19441","DOI":"10.1074\/jbc.C500092200","volume":"280","author":"K Aertgeerts","year":"2005","unstructured":"Aertgeerts, K., Levin, I., Shi, L., et al. (2005). Structural and kinetic analysis of the substrate specificity of human fibroblast activation protein alpha. J Biol Chem, 280, 19441\u201319444. https:\/\/doi.org\/10.1074\/jbc.C500092200.","journal-title":"J Biol Chem"},{"key":"9909_CR26","doi-asserted-by":"publisher","first-page":"4598","DOI":"10.1021\/BI062227Y","volume":"46","author":"SA Meadows","year":"2007","unstructured":"Meadows, S. A., Edosada, C. Y., Mayeda, M., et al. (2007). Ala657 and conserved active site residues promote fibroblast activation protein endopeptidase activity via distinct mechanisms of transition state stabilization. Biochemistry, 46, 4598\u20134605. https:\/\/doi.org\/10.1021\/BI062227Y.","journal-title":"Biochemistry"},{"key":"9909_CR27","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1006\/PREP.2001.1572","volume":"24","author":"S Sun","year":"2002","unstructured":"Sun, S., Albright, C. F., Fish, B. H., et al. (2002). Expression, purification, and kinetic characterization of full-length human fibroblast activation protein. Protein Expr Purif, 24, 274\u2013281. https:\/\/doi.org\/10.1006\/PREP.2001.1572.","journal-title":"Protein Expr Purif"},{"key":"9909_CR28","doi-asserted-by":"publisher","first-page":"4652","DOI":"10.1158\/0008-5472.CAN-05-1245","volume":"66","author":"G Ghersi","year":"2006","unstructured":"Ghersi, G., Zhao, Q., Salamone, M., et al. (2006). The protease complex consisting of dipeptidyl peptidase IV and seprase plays a role in the migration and invasion of human endothelial cells in collagenous matrices. Cancer Res, 66, 4652\u20134661. https:\/\/doi.org\/10.1158\/0008-5472.CAN-05-1245.","journal-title":"Cancer Res"},{"key":"9909_CR29","doi-asserted-by":"publisher","first-page":"24947","DOI":"10.1074\/JBC.274.35.24947","volume":"274","author":"SC Mueller","year":"1999","unstructured":"Mueller, S. C., Ghersi, G., Akiyama, S. K., et al. (1999). A novel protease-docking function of integrin at invadopodia. J Biol Chem, 274, 24947\u201324952. https:\/\/doi.org\/10.1074\/JBC.274.35.24947.","journal-title":"J Biol Chem"},{"key":"9909_CR30","doi-asserted-by":"crossref","unstructured":"Artym, V. V, Kindzelskii, A.L., Chen, W.-T., Petty, H.R. (2002) Molecular proximity of seprase and the urokinase-type plasminogen activator receptor on malignant melanoma cell membranes: dependence on beta1 integrins and the cytoskeleton. Carcinogenesis 23:1593\u20131601","DOI":"10.1093\/carcin\/23.10.1593"},{"key":"9909_CR31","first-page":"4767","volume":"62","author":"JD Cheng","year":"2002","unstructured":"Cheng, J. D., Dunbrack, R. L., Valianou, M., et al. (2002). Promotion of tumor growth by murine fibroblast activation protein, a serine protease, in an animal model. CANCER Res, 62, 4767\u20134772.","journal-title":"CANCER Res"},{"key":"9909_CR32","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1046\/j.1432-1327.1998.2540650.x","volume":"254","author":"J Niedermeyer","year":"1998","unstructured":"Niedermeyer, J., Enenkel, B., Park, J. E., et al. (1998). Mouse fibroblast-activation protein. Conserved Fap gene organization and biochemical function as a serine protease. Eur J Biochem, 254, 650\u2013654. https:\/\/doi.org\/10.1046\/j.1432-1327.1998.2540650.x.","journal-title":"Eur J Biochem"},{"key":"9909_CR33","first-page":"1924","volume":"93","author":"DD Brown","year":"1996","unstructured":"Brown, D. D., Wang, Z., Furlow, J. D., et al. (1996). The thyroid hormone-induced tail resorption program during Xenopus laevis metamorphosis. Dev Biol, 93, 1924\u20131929.","journal-title":"Dev Biol"},{"key":"9909_CR34","doi-asserted-by":"crossref","unstructured":"Zhang, J., Valianou, M., & Cheng, J. D. (2010). Identification and characterization of the promoter of fibroblast activation protein. Front Biosci, 1154\u20131163.","DOI":"10.2741\/e175"},{"key":"9909_CR35","doi-asserted-by":"publisher","first-page":"2554","DOI":"10.1074\/JBC.275.4.2554","volume":"275","author":"LA Goldstein","year":"2000","unstructured":"Goldstein, L. A., & Chen, W. T. (2000). Identification of an alternatively spliced seprase mRNA that encodes a novel intracellular isoform. J Biol Chem, 275, 2554\u20132559. https:\/\/doi.org\/10.1074\/JBC.275.4.2554.","journal-title":"J Biol Chem"},{"key":"9909_CR36","doi-asserted-by":"publisher","unstructured":"Niedermeyer, J., Scanlan, M.J., Garin-Chesa, P., et al (1997) Mouse fibroblast activation protein: Molecular cloning, alternative splicing and expression in the reactive stroma of epithelial cancers. Int J Cancer 71:383\u2013389. https:\/\/doi.org\/10.1002\/(SICI)1097-0215(19970502)71:3<383::AID-IJC14>3.0.CO;2-H","DOI":"10.1002\/(SICI)1097-0215(19970502)71:3<383::AID-IJC14>3.0.CO;2-H"},{"key":"9909_CR37","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/ijc.2910580314","volume":"58","author":"WJ Rettig","year":"1994","unstructured":"Rettig, W. J., Su, S. L., Fortunato, S. R., et al. (1994). Fibroblast activation protein: Purification, epitope mapping and induction by growth factors. Int J Cancer, 58, 385\u2013392. https:\/\/doi.org\/10.1002\/ijc.2910580314.","journal-title":"Int J Cancer"},{"key":"9909_CR38","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/J.YEXMP.2009.09.001","volume":"87","author":"H Chen","year":"2009","unstructured":"Chen, H., Yang, W.-W., Wen, Q.-T., et al. (2009). TGF-\u03b2-induced fibroblast activation protein expression, fibroblast activation protein expression increases the proliferation, adhesion, and migration of HO-8910 PM. Exp Mol Pathol, 87, 189\u2013194. https:\/\/doi.org\/10.1016\/J.YEXMP.2009.09.001.","journal-title":"Exp Mol Pathol"},{"key":"9909_CR39","volume-title":"Ultraviolet exposure of melanoma cells induces fibroblast activation protein-\u03b1 in fibroblasts: Implications for melanoma invasion","author":"P W\u00e4ster","year":"2011","unstructured":"W\u00e4ster, P., Rosdahl, I., Gilmore, B. F., & Seifert, O. (2011). Ultraviolet exposure of melanoma cells induces fibroblast activation protein-\u03b1 in fibroblasts: Implications for melanoma invasion. Faculty of Medicine, Laboratory of Clinical Virology: University of Crete."},{"key":"9909_CR40","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/ijc.23871","volume":"124","author":"A Kennedy","year":"2009","unstructured":"Kennedy, A., Dong, H., Chen, D., & Chen, W.-T. (2009). Elevation of seprase expression and promotion of an invasive phenotype by collagenous matrices in ovarian tumor cells. Int J Cancer, 124, 27\u201335. https:\/\/doi.org\/10.1002\/ijc.23871.","journal-title":"Int J Cancer"},{"key":"9909_CR41","doi-asserted-by":"publisher","first-page":"541","DOI":"10.3892\/ijo.2012.1475","volume":"41","author":"D LAI","year":"2012","unstructured":"LAI, D., MA, L., & WANG, F. (2012). Fibroblast activation protein regulates tumor-associated fibroblasts and epithelial ovarian cancer cells. Int J Oncol, 41, 541\u2013550. https:\/\/doi.org\/10.3892\/ijo.2012.1475.","journal-title":"Int J Oncol"},{"key":"9909_CR42","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20171027","volume":"38","author":"P Ruan","year":"2018","unstructured":"Ruan, P., Tao, Z., & Tan, A. (2018). Low expression of miR-30a-5p induced the proliferation and invasion of oral cancer via promoting the expression of FAP. Biosci Rep, 38, BSR20171027. https:\/\/doi.org\/10.1042\/BSR20171027.","journal-title":"Biosci Rep"},{"key":"9909_CR43","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1046\/j.1365-2443.1996.d01-251.x","volume":"1","author":"A Kanamori","year":"1996","unstructured":"Kanamori, A., & Brown, D. D. (1996). The analysis of complex developmental programmes: Amphibian metamorphosis. Genes to Cells, 1, 429\u2013435. https:\/\/doi.org\/10.1046\/j.1365-2443.1996.d01-251.x.","journal-title":"Genes to Cells"},{"key":"9909_CR44","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1128\/MCB.20.3.1089-1094.2000","volume":"20","author":"J Niedermeyer","year":"2000","unstructured":"Niedermeyer, J., Kriz, M., Hilberg, F., et al. (2000). Targeted disruption of mouse fibroblast activation protein. Mol Cell Biol, 20, 1089\u20131094. https:\/\/doi.org\/10.1128\/MCB.20.3.1089-1094.2000.","journal-title":"Mol Cell Biol"},{"key":"9909_CR45","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1387\/IJDB.11330865","volume":"45","author":"J Niedermeyer","year":"2001","unstructured":"Niedermeyer, J., Garin-Chesa, P., Kriz, M., et al. (2001). Expression of the fibroblast activation protein during mouse embryo development. Int J Dev Biol, 45, 445\u2013447. https:\/\/doi.org\/10.1387\/IJDB.11330865.","journal-title":"Int J Dev Biol"},{"key":"9909_CR46","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1084\/jem.20122344","volume":"210","author":"EW Roberts","year":"2013","unstructured":"Roberts, E. W., Deonarine, A., Jones, J. O., et al. (2013). Depletion of stromal cells expressing fibroblast activation protein-\u03b1 from skeletal muscle and bone marrow results in cachexia and anemia. J Exp Med, 210, 1137\u20131151. https:\/\/doi.org\/10.1084\/jem.20122344.","journal-title":"J Exp Med"},{"key":"9909_CR47","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.fob.2013.12.001","volume":"4","author":"FM Keane","year":"2014","unstructured":"Keane, F. M., Yao, T.-W., Seelk, S., et al. (2014). Quantitation of fibroblast activation protein (FAP)-specific protease activity in mouse, baboon and human fluids and organs. FEBS Open Bio, 4, 43\u201354. https:\/\/doi.org\/10.1016\/j.fob.2013.12.001.","journal-title":"FEBS Open Bio"},{"key":"9909_CR48","first-page":"7235","volume":"87","author":"P Garin-Chesa","year":"1990","unstructured":"Garin-Chesa, P., Oldt, L. J., & Rettigt, W. J. (1990). Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers. Immunology, 87, 7235\u20137239.","journal-title":"Immunology"},{"key":"9909_CR49","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1034\/j.1600-0676.2002.01503.x","volume":"22","author":"M Levy","year":"2002","unstructured":"Levy, M., McCaughan, G., Marinos, G., & Gorrell, M. (2002). Intrahepatic expression of the hepatic stellate cell marker fibroblast activation protein correlates with the degree of fibrosis in hepatitis C virus infection. Liver Int, 22, 93\u2013101. https:\/\/doi.org\/10.1034\/j.1600-0676.2002.01503.x.","journal-title":"Liver Int"},{"key":"9909_CR50","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1111\/jth.12396","volume":"11","author":"S Uitte de Willige","year":"2013","unstructured":"Uitte de Willige, S., Malfliet, J. J. M. C., Janssen, H. L. A., et al. (2013). Increased N-terminal cleavage of alpha-2-antiplasmin in patients with liver cirrhosis. J Thromb Haemost, 11, 2029\u20132036. https:\/\/doi.org\/10.1111\/jth.12396.","journal-title":"J Thromb Haemost"},{"key":"9909_CR51","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0178987","volume":"12","author":"S Uitte de Willige","year":"2017","unstructured":"Uitte de Willige, S., Keane, F. M., Bowen, D. G., Malfliet, J. J. M. C., Zhang, H. E., Maneck, B., McCaughan, G. W., Leebeek, F. W. G., Rijken, D. C., & Gorrell, M. D. (2017). Circulating fibroblast activation protein activity and antigen levels correlate strongly when measured in liver disease and coronary heart disease. PLoS One, 12, e0178987. https:\/\/doi.org\/10.1371\/journal.pone.0178987.","journal-title":"PLoS One"},{"key":"9909_CR52","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/J.DIABRES.2015.02.024","volume":"108","author":"KH Williams","year":"2015","unstructured":"Williams, K. H., Viera de Ribeiro, A. J., Prakoso, E., et al. (2015). Lower serum fibroblast activation protein shows promise in the exclusion of clinically significant liver fibrosis due to non-alcoholic fatty liver disease in diabetes and obesity. Diabetes Res Clin Pract, 108, 466\u2013472. https:\/\/doi.org\/10.1016\/J.DIABRES.2015.02.024.","journal-title":"Diabetes Res Clin Pract"},{"key":"9909_CR53","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.humpath.2005.11.020","volume":"37","author":"PS Acharya","year":"2006","unstructured":"Acharya, P. S., Zukas, A., Chandan, V., Katzenstein, A. L. A., & Pur\u00e9, E. (2006). Fibroblast activation protein: a serine protease expressed at the remodeling interface in idiopathic pulmonary fibrosis. Hum Pathol, 37, 352\u2013360.","journal-title":"Hum Pathol"},{"key":"9909_CR54","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1007\/s10529-015-1855-8","volume":"37","author":"L Wenlong","year":"2015","unstructured":"Wenlong, L., Leilei, Y., Wei, F., et al. (2015). Luciferase expression is driven by the promoter of fibroblast activation protein-\u03b1 in murine pulmonary fibrosis. Biotechnol Lett, 37, 1757\u20131763. https:\/\/doi.org\/10.1007\/s10529-015-1855-8.","journal-title":"Biotechnol Lett"},{"key":"9909_CR55","doi-asserted-by":"publisher","first-page":"8070","DOI":"10.1074\/jbc.M115.701433","volume":"291","author":"M-H Fan","year":"2016","unstructured":"Fan, M.-H., Zhu, Q., Li, H.-H., et al. (2016). Fibroblast activation protein (FAP) accelerates collagen degradation and clearance from lungs in mice. J Biol Chem, 291, 8070\u20138089. https:\/\/doi.org\/10.1074\/jbc.M115.701433.","journal-title":"J Biol Chem"},{"key":"9909_CR56","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.ejphar.2017.05.022","volume":"809","author":"C Egger","year":"2017","unstructured":"Egger, C., Cannet, C., G\u00e9rard, C., et al. (2017). Effects of the fibroblast activation protein inhibitor, PT100, in a murine model of pulmonary fibrosis. Eur J Pharmacol, 809, 64\u201372. https:\/\/doi.org\/10.1016\/j.ejphar.2017.05.022.","journal-title":"Eur J Pharmacol"},{"key":"9909_CR57","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s00403-010-1084-x","volume":"302","author":"K Dienus","year":"2010","unstructured":"Dienus, K., Bayat, A., Gilmore, B. F., & Seifert, O. (2010). Increased expression of fibroblast activation protein-alpha in keloid fibroblasts: implications for development of a novel treatment option. Arch Dermatol Res, 302, 725\u2013731. https:\/\/doi.org\/10.1007\/s00403-010-1084-x.","journal-title":"Arch Dermatol Res"},{"key":"9909_CR58","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1002\/ibd.21446","volume":"17","author":"L Rovedatti","year":"2011","unstructured":"Rovedatti, L., Di Sabatino, A., Knowles, C. H., et al. (2011). Fibroblast activation protein expression in Crohn\u02bcs disease strictures. Inflamm Bowel Dis, 17, 1251\u20131253. https:\/\/doi.org\/10.1002\/ibd.21446.","journal-title":"Inflamm Bowel Dis"},{"key":"9909_CR59","first-page":"1639","volume":"9","author":"AM Scott","year":"2003","unstructured":"Scott, A. M., Wiseman, G., Welt, S., Adjei, A., Lee, F. T., Hopkins, W., Divgi, C. R., Hanson, L. H., Mitchell, P., Gansen, D. N., Larson, S. M., Ingle, J. N., Hoffman, E. W., Tanswell, P., Ritter, G., Cohen, L. S., Bette, P., Arvay, L., Amelsberg, A., Vlock, D., Rettig, W. J., & Old, L. J. (2003). A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer. Clin Cancer Res, 9, 1639\u20131647.","journal-title":"Clin Cancer Res"},{"key":"9909_CR60","doi-asserted-by":"publisher","first-page":"R23","DOI":"10.1186\/ar1877","volume":"8","author":"JM Milner","year":"2006","unstructured":"Milner, J. M., Kevorkian, L., Young, D. A., et al. (2006). Fibroblast activation protein alpha is expressed by chondrocytes following a pro-inflammatory stimulus and is elevated in osteoarthritis. Arthritis Res Ther, 8, R23. https:\/\/doi.org\/10.1186\/ar1877.","journal-title":"Arthritis Res Ther"},{"key":"9909_CR61","doi-asserted-by":"publisher","unstructured":"Bauer, S., Jendro, M. C., Wadle, A., et al. (2006). Fibroblast activation protein is expressed by rheumatoid myofibroblast-like synoviocytes. Arthritis Res Ther, 8. https:\/\/doi.org\/10.1186\/ar2080.","DOI":"10.1186\/ar2080"},{"key":"9909_CR62","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1002\/art.27395","volume":"62","author":"C Ospelt","year":"2010","unstructured":"Ospelt, C., Mertens, J. C., J\u00fcngel, A., et al. (2010). Inhibition of fibroblast activation protein and dipeptidylpeptidase 4 increases cartilage invasion by rheumatoid arthritis synovial fibroblasts. Arthritis Rheum, 62, 1224\u20131235. https:\/\/doi.org\/10.1002\/art.27395.","journal-title":"Arthritis Rheum"},{"key":"9909_CR63","first-page":"433","volume":"166","author":"N Busso","year":"2005","unstructured":"Busso, N., Wagtmann, N., Herling, C., et al. (2005). Circulating CD26 is negatively associated with inflammation in human and experimental arthritis. Immunopathol Infect Dis, 166, 433\u2013442.","journal-title":"Immunopathol Infect Dis"},{"key":"9909_CR64","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13075-015-0524-6","volume":"17","author":"S W\u00e4ldele","year":"2015","unstructured":"W\u00e4ldele, S., Koers-Wunrau, C., Beckmann, D., Korb-Pap, A., Wehmeyer, C., Pap, T., & Dankbar, B. (2015). Deficiency of fibroblast activation protein alpha ameliorates cartilage destruction in inflammatory destructive arthritis. Arthritis Res Ther, 17, 12. https:\/\/doi.org\/10.1186\/s13075-015-0524-6.","journal-title":"Arthritis Res Ther"},{"key":"9909_CR65","doi-asserted-by":"publisher","first-page":"778","DOI":"10.2967\/jnumed.114.152959","volume":"56","author":"P Laverman","year":"2015","unstructured":"Laverman, P., van der Geest, T., Terry, S. Y. A., et al. (2015). Immuno-PET and immuno-SPECT of rheumatoid arthritis with radiolabeled anti-fibroblast activation protein antibody correlates with severity of arthritis. J Nucl Med, 56, 778\u2013783. https:\/\/doi.org\/10.2967\/jnumed.114.152959.","journal-title":"J Nucl Med"},{"key":"9909_CR66","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.1093\/eurheartj\/ehq519","volume":"32","author":"CE Brokopp","year":"2011","unstructured":"Brokopp, C. E., Schoenauer, R., Richards, P., et al. (2011). Fibroblast activation protein is induced by inflammation and degrades type I collagen in thin-cap fibroatheromata. Eur Heart J, 32, 2713\u20132722. https:\/\/doi.org\/10.1093\/eurheartj\/ehq519.","journal-title":"Eur Heart J"},{"key":"9909_CR67","doi-asserted-by":"publisher","first-page":"3926","DOI":"10.1016\/j.ijcard.2013.06.061","volume":"168","author":"J Tillmanns","year":"2013","unstructured":"Tillmanns, J., Widera, C., Habbaba, Y., et al. (2013). Circulating concentrations of fibroblast activation protein \u03b1 in apparently healthy individuals and patients with acute coronary syndrome as assessed by sandwich ELISA \u2606. Int J Cardiol, 168, 3926\u20133931. https:\/\/doi.org\/10.1016\/j.ijcard.2013.06.061.","journal-title":"Int J Cardiol"},{"key":"9909_CR68","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.ijcard.2014.10.091","volume":"178","author":"S Uitte De Willige","year":"2015","unstructured":"Uitte De Willige, S., Malfliet, J. J. M. C., Deckers, J. W., et al. (2015). Plasma levels of soluble fibroblast activation protein in arterial thrombosis; determinants and cleavage of its substrate alpha-2-antiplasmin \u2606. Int J Cardiol, 178, 105\u2013110. https:\/\/doi.org\/10.1016\/j.ijcard.2014.10.091.","journal-title":"Int J Cardiol"},{"key":"9909_CR69","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/J.YJMCC.2015.08.016","volume":"87","author":"J Tillmanns","year":"2015","unstructured":"Tillmanns, J., Hoffmann, D., Habbaba, Y., et al. (2015). Fibroblast activation protein alpha expression identifies activated fibroblasts after myocardial infarction. J Mol Cell Cardiol, 87, 194\u2013203. https:\/\/doi.org\/10.1016\/J.YJMCC.2015.08.016.","journal-title":"J Mol Cell Cardiol"},{"key":"9909_CR70","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.ijcard.2017.01.037","volume":"232","author":"J Tillmanns","year":"2017","unstructured":"Tillmanns, J., Fraccarollo, D., Galuppo, P., et al. (2017). Changes in concentrations of circulating fibroblast activation protein alpha are associated with myocardial damage in patients with acute ST-elevation MI. Int J Cardiol, 232, 155\u2013159. https:\/\/doi.org\/10.1016\/j.ijcard.2017.01.037.","journal-title":"Int J Cardiol"},{"key":"9909_CR71","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1042\/BJ20151085","volume":"473","author":"EY Zhen","year":"2016","unstructured":"Zhen, E. Y., Jin, Z., Ackermann, B. L., et al. (2016). Circulating FGF21 proteolytic processing mediated by fibroblast activation protein. Biochem J, 473, 605\u2013614. https:\/\/doi.org\/10.1042\/BJ20151085.","journal-title":"Biochem J"},{"key":"9909_CR72","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/j.molmet.2016.07.003","volume":"5","author":"MA S\u00e1nchez-Garrido","year":"2016","unstructured":"S\u00e1nchez-Garrido, M. A., Habegger, K. M., Clemmensen, C., Holleman, C., M\u00fcller, T. D., Perez-Tilve, D., Li, P., Agrawal, A. S., Finan, B., Drucker, D. J., Tsch\u00f6p, M. H., DiMarchi, R. D., & Kharitonenkov, A. (2016). Fibroblast activation protein (FAP) as a novel metabolic target. Mol Metab, 5, 1015\u20131024. https:\/\/doi.org\/10.1016\/j.molmet.2016.07.003.","journal-title":"Mol Metab"},{"key":"9909_CR73","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/1746-1596-6-111","volume":"6","author":"X Hua","year":"2011","unstructured":"Hua, X., Yu, L., Huang, X., et al. (2011). Expression and role of fibroblast activation protein-alpha in microinvasive breast carcinoma. Diagn Pathol, 6, 111. https:\/\/doi.org\/10.1186\/1746-1596-6-111.","journal-title":"Diagn Pathol"},{"key":"9909_CR74","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1023\/A:1025493605850","volume":"20","author":"JD Goodman","year":"2003","unstructured":"Goodman, J. D., Rozypal, T. L., & Kelly, T. (2003). Seprase, a membrane-bound protease, alleviates the serum growth requirement of human breast cancer cells. Clin Exp Metastasis, 20, 459\u2013470.","journal-title":"Clin Exp Metastasis"},{"key":"9909_CR75","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s10549-016-3929-2","volume":"159","author":"CK Park","year":"2016","unstructured":"Park, C. K., Jung, W. H., & Koo, J. S. (2016). Expression of cancer-associated fibroblast-related proteins differs between invasive lobular carcinoma and invasive ductal carcinoma. Breast Cancer Res Treat, 159, 55\u201369. https:\/\/doi.org\/10.1007\/s10549-016-3929-2.","journal-title":"Breast Cancer Res Treat"},{"key":"9909_CR76","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s10549-015-3291-9","volume":"149","author":"SY Park","year":"2015","unstructured":"Park, S. Y., Kim, H. M., & Koo, J. S. (2015). Differential expression of cancer-associated fibroblast-related proteins according to molecular subtype and stromal histology in breast cancer. Breast Cancer Res Treat, 149, 727\u2013741. https:\/\/doi.org\/10.1007\/s10549-015-3291-9.","journal-title":"Breast Cancer Res Treat"},{"key":"9909_CR77","doi-asserted-by":"publisher","first-page":"8685","DOI":"10.1007\/s13277-015-3594-9","volume":"36","author":"YY Jung","year":"2015","unstructured":"Jung, Y. Y., Lee, Y. K., & Koo, J. S. (2015). Expression of cancer-associated fibroblast-related proteins in adipose stroma of breast cancer. Tumor Biol, 36, 8685\u20138695. https:\/\/doi.org\/10.1007\/s13277-015-3594-9.","journal-title":"Tumor Biol"},{"key":"9909_CR78","doi-asserted-by":"publisher","first-page":"4341","DOI":"10.1158\/0008-5472.CAN-14-0125","volume":"74","author":"C Gong","year":"2014","unstructured":"Gong, C., Nie, Y., Qu, S., et al. (2014). Molecular and cellular pathobiology miR-21 induces myofibroblast differentiation and promotes the malignant progression of breast phyllodes tumors. Cancer Res, 74, 4341\u20134352. https:\/\/doi.org\/10.1158\/0008-5472.CAN-14-0125.","journal-title":"Cancer Res"},{"key":"9909_CR79","first-page":"370","volume":"31","author":"H Yu","year":"2015","unstructured":"Yu, H., Yang, J., Li, Y., & Jiao, S. (2015). The expression of fibroblast activation protein-\u03b1 in primary breast cancer is associated with poor prognosis. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, 31, 370\u2013374.","journal-title":"Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi"},{"key":"9909_CR80","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1471-2121-15-16","volume":"15","author":"J Jia","year":"2014","unstructured":"Jia, J., Martin, T. A., Ye, L., & Jiang, W. G. (2014). FAP-\u03b1 (fibroblast activation protein-\u03b1) is involved in the control of human breast cancer cell line growth and motility via the FAK pathway. BMC Cell Biol, 15, 16. https:\/\/doi.org\/10.1186\/1471-2121-15-16.","journal-title":"BMC Cell Biol"},{"key":"9909_CR81","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/1097-0215(20010120)95:1<67::AID-IJC1012>3.0.CO;2-U","volume":"95","author":"N Ariga","year":"2001","unstructured":"Ariga, N., Sato, E., Ohuchi, N., et al. (2001). Stromal expression of fibroblast activation protein\/seprase, a cell membrane serine proteinase and gelatinase, is associated with longer survival in patients with invasive ductal carcinoma of breast. Int J cancer, 95, 67\u201372.","journal-title":"Int J cancer"},{"key":"9909_CR82","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1158\/1078-0432.CCR-06-1746","volume":"13","author":"LR Henry","year":"2007","unstructured":"Henry, L. R., Lee, H.-O., Lee, J. S., et al. (2007). Clinical implications of fibroblast activation protein in patients with colon cancer. Clin Cancer Res, 13, 1736\u20131741. https:\/\/doi.org\/10.1158\/1078-0432.CCR-06-1746.","journal-title":"Clin Cancer Res"},{"key":"9909_CR83","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1007\/s13277-012-0638-2","volume":"34","author":"ML Wikberg","year":"2013","unstructured":"Wikberg, M. L., Edin, S., Lundberg, I. V., Lundberg, I. V., van Guelpen, B., Dahlin, A. M., Ruteg\u00e5rd, J., Stenling, R., \u00d6berg, \u00c5., & Palmqvist, R. (2013). High intratumoral expression of fibroblast activation protein (FAP) in colon cancer is associated with poorer patient prognosis. Tumor Biol, 34, 1013\u20131020. https:\/\/doi.org\/10.1007\/s13277-012-0638-2.","journal-title":"Tumor Biol"},{"key":"9909_CR84","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.1158\/0008-5472.CAN-15-2973","volume":"76","author":"X Yang","year":"2016","unstructured":"Yang, X., Lin, Y., Shi, Y., Li, B., Liu, W., Yin, W., Dang, Y., Chu, Y., Fan, J., & He, R. (2016). FAP promotes immunosuppression by cancer-associated fibroblasts in the tumor microenvironment via STAT3-CCL2 signaling. Cancer Res, 76, 4124\u20134135. https:\/\/doi.org\/10.1158\/0008-5472.CAN-15-2973.","journal-title":"Cancer Res"},{"key":"9909_CR85","doi-asserted-by":"publisher","first-page":"840","DOI":"10.3748\/wjg.v18.i8.840","volume":"18","author":"M Shi","year":"2012","unstructured":"Shi, M., Yu, D.-H., Chen, Y., et al. (2012). Expression of fibroblast activation protein in human pancreatic adenocarcinoma and its clinicopathological significance. World J Gastroenterol, 18, 840\u2013846. https:\/\/doi.org\/10.3748\/wjg.v18.i8.840.","journal-title":"World J Gastroenterol"},{"key":"9909_CR86","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1097\/MPA.0b013e31816618ce","volume":"37","author":"SJ Cohen","year":"2008","unstructured":"Cohen, S. J., Alpaugh, R. K., Palazzo, I., et al. (2008). Fibroblast activation protein and its relationship to clinical outcome in pancreatic adenocarcinoma. Pancreas, 37, 154\u2013158. https:\/\/doi.org\/10.1097\/MPA.0b013e31816618ce.","journal-title":"Pancreas"},{"key":"9909_CR87","doi-asserted-by":"publisher","first-page":"20212","DOI":"10.1073\/pnas.1320318110","volume":"110","author":"C Feig","year":"2013","unstructured":"Feig, C., Jones, J. O., Kraman, M., et al. (2013). Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer. Proc Natl Acad Sci U S A, 110, 20212\u201320217. https:\/\/doi.org\/10.1073\/pnas.1320318110.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9909_CR88","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12876-015-0340-0","volume":"15","author":"T Kawase","year":"2015","unstructured":"Kawase, T., Yasui, Y., Nishina, S., et al. (2015). Fibroblast activation protein-\u03b1-expressing fibroblasts promote the progression of pancreatic ductal adenocarcinoma. BMC Gastroenterol, 15, 109. https:\/\/doi.org\/10.1186\/s12876-015-0340-0.","journal-title":"BMC Gastroenterol"},{"key":"9909_CR89","doi-asserted-by":"publisher","unstructured":"Park, H., Lee, Y., Lee, H., et al. (2017). The prognostic significance of cancer-associated fibroblasts in pancreatic ductal adenocarcinoma. Tumor Biol 1\u20139. https:\/\/doi.org\/10.1177\/1010428317718403.","DOI":"10.1177\/1010428317718403"},{"key":"9909_CR90","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1159\/000074650","volume":"65","author":"K Okada","year":"2003","unstructured":"Okada, K., Chen, W.-T., Iwasa, S., et al. (2003). Seprase, a membrane-type serine protease, has different expression patterns in intestinal- and diffuse-type gastric cancer. Oncology, 65, 363\u2013370. https:\/\/doi.org\/10.1159\/000074650.","journal-title":"Oncology"},{"key":"9909_CR91","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1089\/omi.2016.0159","volume":"21","author":"M Hu","year":"2017","unstructured":"Hu, M., Qian, C., Hu, Z., et al. (2017). Biomarkers in tumor microenvironment? Upregulation of fibroblast activation protein-\u03b1 correlates with gastric cancer progression and poor prognosis. Omi A J Integr Biol, 21, 38\u201344. https:\/\/doi.org\/10.1089\/omi.2016.0159.","journal-title":"Omi A J Integr Biol"},{"key":"9909_CR92","doi-asserted-by":"publisher","first-page":"629","DOI":"10.3727\/096504016X14768383625385","volume":"25","author":"X Wen","year":"2017","unstructured":"Wen, X., He, X., Jiao, F., et al. (2017). Fibroblast activation protein-\u03b1-positive fibroblasts promote gastric cancer progression and resistance to immune checkpoint blockade. Oncol Res Featur Preclin Clin Cancer Ther, 25, 629\u2013640. https:\/\/doi.org\/10.3727\/096504016X14768383625385.","journal-title":"Oncol Res Featur Preclin Clin Cancer Ther"},{"key":"9909_CR93","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/j.bbrc.2018.02.193","volume":"497","author":"R Dong","year":"2018","unstructured":"Dong, R., Guo, J., Zhang, Z., Zhou, Y., & Hua, Y. (2018). Polyphyllin I inhibits gastric cancer cell proliferation by downregulating the expression of fibroblast activation protein alpha (FAP) and hepatocyte growth factor (HGF) in cancer-associated fibroblasts. Biochem Biophys Res Commun, 497, 1129\u20131134. https:\/\/doi.org\/10.1016\/j.bbrc.2018.02.193.","journal-title":"Biochem Biophys Res Commun"},{"key":"9909_CR94","first-page":"6406","volume":"46","author":"WJ Rettig","year":"1986","unstructured":"Rettig, W. J., Chesa, P. G., Beresford, H. R., et al. (1986). Differential expression of cell surface antigens and glial fibrillary acidic protein in human astrocytoma subsets. Cancer Res, 46, 6406\u20136412.","journal-title":"Cancer Res"},{"key":"9909_CR95","doi-asserted-by":"publisher","first-page":"785","DOI":"10.3892\/ijo.31.4.785","volume":"31","author":"J Stremenova","year":"2007","unstructured":"Stremenova, J., Krepela, E., Mares, V., et al. (2007). Expression and enzymatic activity of dipeptidyl peptidase-IV in human astrocytic tumours are associated with tumour grade. Int J Oncol, 31, 785\u2013792. https:\/\/doi.org\/10.3892\/ijo.31.4.785.","journal-title":"Int J Oncol"},{"key":"9909_CR96","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/1476-4598-9-194","volume":"9","author":"SA Mikheeva","year":"2010","unstructured":"Mikheeva, S. A., Mikheev, A. M., Petit, A., et al. (2010). TWIST1 promotes invasion through mesenchymal change in human glioblastoma. Mol Cancer, 9, 194.","journal-title":"Mol Cancer"},{"key":"9909_CR97","doi-asserted-by":"publisher","first-page":"252","DOI":"10.5507\/bp.2017.010","volume":"161","author":"I Matrasova","year":"2017","unstructured":"Matrasova, I., Busek, P., Balaziova, E., & Sedo, A. (2017). Heterogeneity of molecular forms of dipeptidyl peptidase-IV and fibroblast activation protein in human glioblastomas. Biomed Pap, 161, 252\u2013260. https:\/\/doi.org\/10.5507\/bp.2017.010.","journal-title":"Biomed Pap"},{"key":"9909_CR98","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1515\/BC.2010.119","volume":"392","author":"R Mentlein","year":"2011","unstructured":"Mentlein, R., Hattermann, K., Hemion, C., et al. (2011). Expression and role of the cell surface protease seprase\/fibroblast activation protein-a (FAP-a) in astroglial tumors. Biol Chem, 392, 199\u2013207. https:\/\/doi.org\/10.1515\/BC.2010.119.","journal-title":"Biol Chem"},{"key":"9909_CR99","doi-asserted-by":"publisher","first-page":"13961","DOI":"10.1007\/s13277-016-5274-9","volume":"37","author":"P Busek","year":"2016","unstructured":"Busek, P., Balaziova, E., Matrasova, I., et al. (2016). Fibroblast activation protein alpha is expressed by transformed and stromal cells and is associated with mesenchymal features in glioblastoma. Tumor Biol, 37, 13961\u201313971. https:\/\/doi.org\/10.1007\/s13277-016-5274-9.","journal-title":"Tumor Biol"},{"key":"9909_CR100","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/J.CANLET.2011.01.011","volume":"303","author":"Y Zhang","year":"2011","unstructured":"Zhang, Y., Tang, H., Cai, J., et al. (2011). Ovarian cancer-associated fibroblasts contribute to epithelial ovarian carcinoma metastasis by promoting angiogenesis, lymphangiogenesis and tumor cell invasion. Cancer Lett, 303, 47\u201355. https:\/\/doi.org\/10.1016\/J.CANLET.2011.01.011.","journal-title":"Cancer Lett"},{"key":"9909_CR101","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1093\/abbs\/gmt095","volume":"45","author":"L Yang","year":"2013","unstructured":"Yang, L., Ma, L., & Lai, D. (2013). Over-expression of fibroblast activation protein alpha increases tumor growth in xenografts of ovarian cancer cells. Acta Biochim Biophys Sin, 45, 928\u2013937. https:\/\/doi.org\/10.1093\/abbs\/gmt095.","journal-title":"Acta Biochim Biophys Sin"},{"key":"9909_CR102","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1097\/00029330-200704020-00010","volume":"120","author":"M-Z Zhang","year":"2007","unstructured":"Zhang, M.-Z., Qiao, Y.-H., Nesland, J. M., et al. (2007). Expression of seprase in effusions from patients with epithelial ovarian carcinoma. Chin Med J (Engl), 120, 663\u2013668.","journal-title":"Chin Med J (Engl)"},{"key":"9909_CR103","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3892\/ol.2015.3151","volume":"10","author":"M Zhang","year":"2015","unstructured":"Zhang, M., Xu, L., Wang, X., et al. (2015). Expression levels of seprase\/FAP\u03b1 and DPPIV\/CD26 in epithelial ovarian carcinoma. Oncol Lett, 10, 34\u201342. https:\/\/doi.org\/10.3892\/ol.2015.3151.","journal-title":"Oncol Lett"},{"key":"9909_CR104","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/j.1365-2141.2006.05976.x","volume":"133","author":"Y Ge","year":"2006","unstructured":"Ge, Y., Zhan, F., Barlogie, B., et al. (2006). Fibroblast activation protein (FAP) is upregulated in myelomatous bone and supports myeloma cell survival. Br J Haematol, 133, 83\u201392. https:\/\/doi.org\/10.1111\/j.1365-2141.2006.05976.x.","journal-title":"Br J Haematol"},{"key":"9909_CR105","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1111\/j.1365-2141.2009.07696.x","volume":"145","author":"A Pennisi","year":"2009","unstructured":"Pennisi, A., Li, X., Ling, W., Khan, S., Gaddy, D., Suva, L. J., Barlogie, B., Shaughnessy, J. D., Aziz, N., & Yaccoby, S. (2009). Inhibitor of DASH proteases affects expression of adhesion molecules in osteoclasts and reduces myeloma growth and bone disease. Br J Haematol, 145, 775\u2013787. https:\/\/doi.org\/10.1111\/j.1365-2141.2009.07696.x.","journal-title":"Br J Haematol"},{"key":"9909_CR106","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1046\/J.1523-1747.2003.12035.X","volume":"120","author":"MA Huber","year":"2003","unstructured":"Huber, M. A., Schubert, R. D., Peter, R. U., Kraut, N., Park, J. E., Rettig, W. J., & Garin-Chesa, P. (2003). Fibroblast activation protein: Differential expression and serine protease activity in reactive stromal fibroblasts of melanocytic skin tumors. J Invest Dermatol, 120, 182\u2013188. https:\/\/doi.org\/10.1046\/J.1523-1747.2003.12035.X.","journal-title":"J Invest Dermatol"},{"key":"9909_CR107","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0116683","volume":"10","author":"F Liu","year":"2015","unstructured":"Liu, F., Qi, L., Liu, B., et al. (2015). Fibroblast activation protein overexpression and clinical implications in solid tumors: A meta-analysis. PLoS One, 10, e0116683. https:\/\/doi.org\/10.1371\/journal.pone.0116683.","journal-title":"PLoS One"},{"key":"9909_CR108","doi-asserted-by":"publisher","first-page":"27221","DOI":"10.1074\/JBC.271.44.27221","volume":"271","author":"H Nakahara","year":"1996","unstructured":"Nakahara, H., Nomizu, M., Akiyama, S. K., et al. (1996). A mechanism for regulation of melanoma invasion. Ligation of alpha6beta1 integrin by laminin G peptides. J Biol Chem, 271, 27221\u201327224. https:\/\/doi.org\/10.1074\/JBC.271.44.27221.","journal-title":"J Biol Chem"},{"key":"9909_CR109","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.yexmp.2013.06.007","volume":"95","author":"W Yang","year":"2013","unstructured":"Yang, W., Han, W., Ye, S., et al. (2013). Fibroblast activation protein-\u03b1 promotes ovarian cancer cell proliferation and invasion via extracellular and intracellular signaling mechanisms. Exp Mol Pathol, 95, 105\u2013110. https:\/\/doi.org\/10.1016\/j.yexmp.2013.06.007.","journal-title":"Exp Mol Pathol"},{"key":"9909_CR110","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1186\/1471-2407-11-245","volume":"11","author":"H-O Lee","year":"2011","unstructured":"Lee, H.-O., Mullins, S. R., Franco-Barraza, J., Valianou, M., Cukierman, E., & Cheng, J. D. (2011). FAP-overexpressing fibroblasts produce an extracellular matrix that enhances invasive velocity and directionality of pancreatic cancer cells. BMC Cancer, 11, 245. https:\/\/doi.org\/10.1186\/1471-2407-11-245.","journal-title":"BMC Cancer"},{"key":"9909_CR111","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3892\/ijmm.2017.3224","volume":"41","author":"J Jia","year":"2017","unstructured":"Jia, J., Martin, T., Ye, L., et al. (2017). Fibroblast activation protein-\u03b1 promotes the growth and migration of lung cancer cells via the PI3K and sonic hedgehog pathways. Int J Mol Med, 41, 275\u2013283. https:\/\/doi.org\/10.3892\/ijmm.2017.3224.","journal-title":"Int J Mol Med"},{"key":"9909_CR112","doi-asserted-by":"publisher","unstructured":"Wang, H., Wu, Q., Liu, Z., et al. (2014). Downregulation of FAP suppresses cell proliferation and metastasis through PTEN\/PI3K\/AKT and Ras-ERK signaling in oral squamous cell carcinoma. Cell Death Dis, 122. https:\/\/doi.org\/10.1038\/cddis.2014.122.","DOI":"10.1038\/cddis.2014.122"},{"key":"9909_CR113","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1055\/s-0037-1613388","volume":"89","author":"RT Aimes","year":"2003","unstructured":"Aimes, R. T., Zijlstra, A., Hooper, J. D., et al. (2003). Endothelial cell serine proteases expressed during vascular morphogenesis and angiogenesis. Thromb Haemost, 89, 561\u2013572.","journal-title":"Thromb Haemost"},{"key":"9909_CR114","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12253-017-0359-3","volume":"25","author":"L-M Gao","year":"2017","unstructured":"Gao, L.-M., Wang, F., Zheng, Y., Fu, Z. Z., Zheng, L., & Chen, L. L. (2017). Roles of fibroblast activation protein and hepatocyte growth factor expressions in angiogenesis and metastasis of gastric cancer. Pathol Oncol Res, 25, 1\u20138. https:\/\/doi.org\/10.1007\/s12253-017-0359-3.","journal-title":"Pathol Oncol Res"},{"key":"9909_CR115","doi-asserted-by":"publisher","first-page":"3613","DOI":"10.1172\/JCI38988","volume":"119","author":"AM Santos","year":"2009","unstructured":"Santos, A. M., Jung, J., Aziz, N., Kissil, J. L., & Pur\u00e9, E. (2009). Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice. J Clin Invest, 119, 3613\u20133625. https:\/\/doi.org\/10.1172\/JCI38988.","journal-title":"J Clin Invest"},{"key":"9909_CR116","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1593\/NEO.121850","volume":"15","author":"VJ Christiansen","year":"2013","unstructured":"Christiansen, V. J., Jackson, K. W., Lee, K. N., et al. (2013). Targeting inhibition of fibroblast activation protein-\u03b1 and prolyl oligopeptidase activities on cells common to metastatic tumor microenvironments. Neoplasia, 15, 348\u2013358. https:\/\/doi.org\/10.1593\/NEO.121850.","journal-title":"Neoplasia"},{"key":"9909_CR117","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.2353\/ajpath.2008.070988","volume":"172","author":"R Bhati","year":"2008","unstructured":"Bhati, R., Patterson, C., Livasy, C. A., et al. (2008). Molecular characterization of human breast tumor vascular cells. Am J Pathol, 172, 1381\u20131390. https:\/\/doi.org\/10.2353\/ajpath.2008.070988.","journal-title":"Am J Pathol"},{"key":"9909_CR118","doi-asserted-by":"publisher","unstructured":"Zukowska, Z., Grant, D.S., Lee, E.W. (2003) Neuropeptide Y: A novel mechanism for ischemic angiogenesis. Trends Cardiovasc Med 13:86\u201392. https:\/\/doi.org\/10.1016\/S1050-1738(02)00232-3","DOI":"10.1016\/S1050-1738"},{"key":"9909_CR119","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/S0092-8674(00)81169-1","volume":"93","author":"TH Vu","year":"1998","unstructured":"Vu, T. H., Shipley, J. M., Bergers, G., et al. (1998). MMP-9\/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell, 93, 411\u2013422.","journal-title":"Cell"},{"key":"9909_CR120","doi-asserted-by":"publisher","unstructured":"Kahounov\u00e1, Z., Kurf\u00fcrstov\u00e1, D., Bouchal, J., et al. (2017). The fibroblast surface markers FAP, anti-fibroblast, and FSP are expressed by cells of epithelial origin and may be altered during epithelial-to-mesenchymal transition. Cytom Part A. https:\/\/doi.org\/10.1002\/cyto.a.23101.","DOI":"10.1002\/cyto.a.23101"},{"key":"9909_CR121","doi-asserted-by":"publisher","unstructured":"Kraman, M., Bambrough, P. J., Arnold, J. N., et al. (2010). Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein. Science (80- ) 330:827\u2013830. https:\/\/doi.org\/10.1126\/science.1195300.","DOI":"10.1126\/science.1195300"},{"key":"9909_CR122","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.bbrc.2017.03.039","volume":"487","author":"L Chen","year":"2017","unstructured":"Chen, L., Qiu, X., Wang, X., & He, J. (2017). FAP positive fibroblasts induce immune checkpoint blockade resistance in colorectal cancer via promoting immunosuppression. Biochem Biophys Res Commun, 487, 8\u201314. https:\/\/doi.org\/10.1016\/j.bbrc.2017.03.039.","journal-title":"Biochem Biophys Res Commun"},{"key":"9909_CR123","doi-asserted-by":"publisher","first-page":"64274","DOI":"10.18632\/oncotarget.11729","volume":"7","author":"C Sorrentino","year":"2016","unstructured":"Sorrentino, C., Miele, L., Porta, A., Pinto, A., & Morello, S. (2016). Activation of the A2B adenosine receptor in B16 melanomas induces CXCL12 expression in FAP-positive tumor stromal cells, enhancing tumor progression. Oncotarget, 7, 64274\u201364288. https:\/\/doi.org\/10.18632\/oncotarget.11729.","journal-title":"Oncotarget"},{"key":"9909_CR124","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0192157","volume":"13","author":"TK Kilvaer","year":"2018","unstructured":"Kilvaer, T. K., Rakaee, M., Hellevik, T., et al. (2018). Tissue analyses reveal a potential immune-adjuvant function of FAP-1 positive fibroblasts in non-small cell lung cancer. PLoS One, 13, e0192157. https:\/\/doi.org\/10.1371\/journal.pone.0192157.","journal-title":"PLoS One"},{"key":"9909_CR125","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0088772","volume":"9","author":"K-M Chung","year":"2014","unstructured":"Chung, K.-M., Hsu, S.-C., Chu, Y.-R., et al. (2014). Fibroblast activation protein (FAP) is essential for the migration of bone marrow mesenchymal stem cells through RhoA activation. PLoS One, 9, e88772. https:\/\/doi.org\/10.1371\/journal.pone.0088772.","journal-title":"PLoS One"},{"key":"9909_CR126","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1756-9966-33-34","volume":"33","author":"D Yue","year":"2014","unstructured":"Yue, D., Li, H., Che, J., et al. (2014). Hedgehog\/Gli promotes epithelial-mesenchymal transition in lung squamous cell carcinomas. J Exp Clin Cancer Res, 33, 34. https:\/\/doi.org\/10.1186\/1756-9966-33-34.","journal-title":"J Exp Clin Cancer Res"},{"key":"9909_CR127","doi-asserted-by":"publisher","first-page":"5995","DOI":"10.1158\/1078-0432.CCR-08-0291","volume":"14","author":"JM Bailey","year":"2008","unstructured":"Bailey, J. M., Swanson, B. J., Hamada, T., Eggers, J. P., Singh, P. K., Caffery, T., Ouellette, M. M., & Hollingsworth, M. A. (2008). Sonic hedgehog promotes desmoplasia in pancreatic cancer. Clin Cancer Res, 14, 5995\u20136004. https:\/\/doi.org\/10.1158\/1078-0432.CCR-08-0291.","journal-title":"Clin Cancer Res"},{"key":"9909_CR128","doi-asserted-by":"publisher","unstructured":"Walsh, M. P., Duncan, B., Larabee, S., et al. (2013). Val-BoroPro accelerates T Cell priming via modulation of dendritic cell trafficking resulting in complete regression of established murine tumors. PLoS One, 8. https:\/\/doi.org\/10.1371\/journal.pone.0058860.","DOI":"10.1371\/journal.pone.0058860"},{"key":"9909_CR129","doi-asserted-by":"publisher","first-page":"5471","DOI":"10.1158\/0008-5472.CAN-04-0447","volume":"64","author":"S Adams","year":"2004","unstructured":"Adams, S., Miller, G. T., Jesson, M. I., et al. (2004). PT-100, a small molecule dipeptidyl peptidase inhibitor, has potent antitumor effects and augments antibody-mediated cytotoxicity via a novel immune mechanism. CANCER Res, 64, 5471\u20135480.","journal-title":"CANCER Res"},{"key":"9909_CR130","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.3892\/mmr.2016.4868","volume":"13","author":"M Li","year":"2016","unstructured":"Li, M., Li, M., Yin, T., et al. (2016). Targeting of cancer-associated fibroblasts enhances the efficacy of cancer chemotherapy by regulating the tumor microenvironment. Mol Med Rep, 13, 2476\u20132484. https:\/\/doi.org\/10.3892\/mmr.2016.4868.","journal-title":"Mol Med Rep"},{"key":"9909_CR131","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/nchembio.2229","volume":"13","author":"MC Okondo","year":"2017","unstructured":"Okondo, M. C., Johnson, D. C., Sridharan, R., et al. (2017). DPP8 and DPP9 inhibition induces pro-caspase-1-dependent monocyte and macrophage pyroptosis. Nat Chem Biol, 13, 46\u201353. https:\/\/doi.org\/10.1038\/nchembio.2229.","journal-title":"Nat Chem Biol"},{"key":"9909_CR132","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1093\/jnci\/djq174","volume":"102","author":"H Meany","year":"2010","unstructured":"Meany, H., Balis, F. M., Aikin, A., Whitcomb, P., Murphy, R. F., Steinberg, S. M., Widemann, B. C., & Fox, E. (2010). Pediatric phase i trial design using maximum target inhibition as the primary endpoint. J Natl Cancer Inst, 102, 909\u2013912. https:\/\/doi.org\/10.1093\/jnci\/djq174.","journal-title":"J Natl Cancer Inst"},{"key":"9909_CR133","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1186\/1471-2407-9-263","volume":"9","author":"RM Eager","year":"2009","unstructured":"Eager, R. M., Cunningham, C. C., Senzer, N. N., et al. (2009). Phase II assessment of talabostat and cisplatin in second-line stage IV melanoma. BMC Cancer, 9, 263. https:\/\/doi.org\/10.1186\/1471-2407-9-263.","journal-title":"BMC Cancer"},{"key":"9909_CR134","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/J.CLON.2009.04.007","volume":"21","author":"RM Eager","year":"2009","unstructured":"Eager, R. M., Cunningham, C. C., Senzer, N., et al. (2009). Phase II trial of talabostat and docetaxel in advanced non-small cell lung cancer. Clin Oncol, 21, 464\u2013472. https:\/\/doi.org\/10.1016\/J.CLON.2009.04.007.","journal-title":"Clin Oncol"},{"key":"9909_CR135","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1182\/blood-2003-01-0208","volume":"102","author":"B Jones","year":"2003","unstructured":"Jones, B., Adams, S., Miller, G. T., et al. (2003). Hematopoietic stimulation by a dipeptidyl peptidase inhibitor reveals a novel regulatory mechanism and therapeutic treatment for blood cell deficiencies. Blood, 102, 1641\u20131648. https:\/\/doi.org\/10.1182\/blood-2003-01-0208.","journal-title":"Blood"},{"key":"9909_CR136","doi-asserted-by":"publisher","first-page":"3053","DOI":"10.1021\/jm500031w","volume":"57","author":"K Jansen","year":"2014","unstructured":"Jansen, K., Heirbaut, L., Verkerk, R., et al. (2014). Extended structure\u2212activity relationship and pharmacokinetic investigation of (4-Quinolinoyl)glycyl-2-cyanopyrrolidine inhibitors of fibroblast activation protein (FAP). J Med Chem, 57, 3053\u20133074. https:\/\/doi.org\/10.1021\/jm500031w.","journal-title":"J Med Chem"},{"key":"9909_CR137","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/j.1365-2125.2001.01335.x","volume":"51","author":"P Tanswell","year":"2001","unstructured":"Tanswell, P., Garin-Chesa, P., Rettig, W. J., Welt, S., Divgi, C. R., Casper, E. S., Finn, R. D., Larson, S. M., Old, L. J., & Scott, A. M. (2001). Population pharmacokinetics of antifibroblast activation protein monoclonal antibody F19 in cancer patients. Br J Clin Pharmacol, 51, 177\u2013180. https:\/\/doi.org\/10.1111\/j.1365-2125.2001.01335.x.","journal-title":"Br J Clin Pharmacol"},{"key":"9909_CR138","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1200\/JCO.1994.12.6.1193","volume":"12","author":"S Welt","year":"1994","unstructured":"Welt, S., Divgi, C. R., Scott, A. M., et al. (1994). Antibody targeting in metastatic colon cancer: a phase I study of monoclonal antibody F19 against a cell-surface protein of reactive tumor stromal fibroblasts. J Clin Oncol, 12, 1193\u20131203. https:\/\/doi.org\/10.1200\/JCO.1994.12.6.1193.","journal-title":"J Clin Oncol"},{"key":"9909_CR139","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1096\/fj.12-210377","volume":"27","author":"J Zhang","year":"2013","unstructured":"Zhang, J., Valianou, M., Simmons, H., et al. (2013). Identification of inhibitory scFv antibodies targeting fibroblast activation protein utilizing phage display functional screens. FASEB J, 27, 581\u2013589. https:\/\/doi.org\/10.1096\/fj.12-210377.","journal-title":"FASEB J"},{"key":"9909_CR140","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1046\/j.1432-1327.2001.02046.x","volume":"268","author":"A Schmidt","year":"2001","unstructured":"Schmidt, A., M\u00fcller, D., Mersmann, M., W\u00fcest, T., Gerlach, E., Garin-Chesa, P., Rettig, W. J., Pfizenmaier, K., & Moosmayer, D. (2001). Generation of human high-affinity antibodies specific for the fibroblast activation protein by guided selection. Eur J Biochem, 268, 1730\u20131738.","journal-title":"Eur J Biochem"},{"key":"9909_CR141","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S0168-1656(01)00355-8","volume":"92","author":"T W\u00fcest","year":"2001","unstructured":"W\u00fcest, T., Moosmayer, D., & Pfizenmaier, K. (2001). Construction of a bispecific single chain antibody for recruitment of cytotoxic T cells to the tumour stroma associated antigen fibroblast activation protein. J Biotechnol, 92, 159\u2013168.","journal-title":"J Biotechnol"},{"key":"9909_CR142","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1097\/CJI.0b013e3182594387","volume":"35","author":"N Hornig","year":"2012","unstructured":"Hornig, N., Kermer, V., Frey, K., et al. (2012). Combination of a bispecific antibody and costimulatory antibody-ligand fusion proteins for targeted cancer immunotherapy. J Immunother, 35, 418\u2013429. https:\/\/doi.org\/10.1097\/CJI.0b013e3182594387.","journal-title":"J Immunother"},{"key":"9909_CR143","doi-asserted-by":"publisher","unstructured":"Hofheinz, R.-D., al-Batran, S.-E., Hartmann, F., et al (2003) Stromal antigen targeting by a humanised monoclonal antibody: An early phase II trial of sibrotuzumab in patients with metastatic colorectal cancer. Oncol Res Treat 26:44\u201348. https:\/\/doi.org\/10.1159\/000069863","DOI":"10.1159\/000069863"},{"key":"9909_CR144","doi-asserted-by":"publisher","first-page":"6208","DOI":"10.1158\/1078-0432.CCR-12-0644","volume":"18","author":"E Fischer","year":"2012","unstructured":"Fischer, E., Chaitanya, K., W\u00fcest, T., et al. (2012). Radioimmunotherapy of fibroblast activation protein positive tumors by rapidly internalizing antibodies. Clin Cancer Res, 18, 6208\u20136218. https:\/\/doi.org\/10.1158\/1078-0432.CCR-12-0644.","journal-title":"Clin Cancer Res"},{"key":"9909_CR145","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.ejphar.2017.09.016","volume":"815","author":"J Wang","year":"2017","unstructured":"Wang, J., Li, Q., Li, X., et al. (2017). A novel FAP\u03b1-based Z-Gly-Pro epirubicin prodrug for improving tumor- targeting chemotherapy. Eur J Pharmacol, 815, 166\u2013172. https:\/\/doi.org\/10.1016\/j.ejphar.2017.09.016.","journal-title":"Eur J Pharmacol"},{"key":"9909_CR146","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/CAD.0000000000000593","volume":"29","author":"S Huang","year":"2018","unstructured":"Huang, S., Zhang, Y., Zhong, J., et al. (2018). Toxicological profile and safety pharmacology of a single dose of fibroblast activation protein-\u03b1-based doxorubicin prodrug. Anticancer Drugs, 29, 1. https:\/\/doi.org\/10.1097\/CAD.0000000000000593.","journal-title":"Anticancer Drugs"},{"key":"9909_CR147","doi-asserted-by":"publisher","first-page":"3689","DOI":"10.1172\/JCI94258","volume":"127","author":"M Chen","year":"2017","unstructured":"Chen, M., Lei, X., Shi, C., Huang, M., Li, X., Wu, B., Li, Z., Han, W., du, B., Hu, J., Nie, Q., Mai, W., Ma, N., Xu, N., Zhang, X., Fan, C., Hong, A., Xia, M., Luo, L., Ma, A., Li, H., Yu, Q., Chen, H., Zhang, D., & Ye, W. (2017). Pericyte-targeting prodrug overcomes tumor resistance to vascular disrupting agents. J Clin Invest, 127, 3689\u20133701. https:\/\/doi.org\/10.1172\/JCI94258.","journal-title":"J Clin Invest"},{"key":"9909_CR148","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1172\/JCI26532","volume":"116","author":"M Loeffler","year":"2006","unstructured":"Loeffler, M., Kr\u00fcger, J. A., Niethammer, A. G., & Reisfeld, R. A. (2006). Targeting tumor-associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake. J Clin Invest, 116, 1955\u20131962. https:\/\/doi.org\/10.1172\/JCI26532.","journal-title":"J Clin Invest"},{"key":"9909_CR149","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1111\/j.1349-7006.2010.01695.x","volume":"101","author":"Y Wen","year":"2010","unstructured":"Wen, Y., Wang, C.-T., Ma, T.-T., Li, Z. Y., Zhou, L. N., Mu, B., Leng, F., Shi, H. S., Li, Y. O., & Wei, Y. Q. (2010). Immunotherapy targeting fibroblast activation protein inhibits tumor growth and increases survival in a murine colon cancer model. Cancer Sci, 101, 2325\u20132332. https:\/\/doi.org\/10.1111\/j.1349-7006.2010.01695.x.","journal-title":"Cancer Sci"},{"key":"9909_CR150","doi-asserted-by":"publisher","first-page":"14421","DOI":"10.1038\/srep14421","volume":"5","author":"M Chen","year":"2015","unstructured":"Chen, M., Xiang, R., Wen, Y., et al. (2015). A whole-cell tumor vaccine modified to express fibroblast activation protein induces antitumor immunity against both tumor cells and cancer-associated fibroblasts. Sci Rep, 5, 14421. https:\/\/doi.org\/10.1038\/srep14421.","journal-title":"Sci Rep"},{"key":"9909_CR151","doi-asserted-by":"publisher","unstructured":"Gottschalk, S., Yu, F., Ji, M., et al. (2013). A vaccine that co-targets tumor cells and cancer associated fibroblasts results in enhanced antitumor activity by inducing antigen spreading. PLoS One, 8. https:\/\/doi.org\/10.1371\/journal.pone.0082658.","DOI":"10.1371\/journal.pone.0082658"},{"key":"9909_CR152","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.retram.2018.03.005","volume":"66","author":"A Ghobadi","year":"2018","unstructured":"Ghobadi, A. (2018). Chimeric antigen receptor T cell therapy for non-Hodgkin lymphoma. Curr Res Transl Med, 66, 43\u201349. https:\/\/doi.org\/10.1016\/j.retram.2018.03.005.","journal-title":"Curr Res Transl Med"},{"key":"9909_CR153","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1479-5876-11-187","volume":"11","author":"PC Schuberth","year":"2013","unstructured":"Schuberth, P. C., Hagedorn, C., Jensen, S. M., et al. (2013). Treatment of malignant pleural mesothelioma by fibroblast activation protein-specific re-directed T cells. J Transl Med, 11, 1\u201311. https:\/\/doi.org\/10.1186\/1479-5876-11-187.","journal-title":"J Transl Med"},{"key":"9909_CR154","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1038\/mt.2013.110","volume":"21","author":"S Kakarla","year":"2013","unstructured":"Kakarla, S., Chow, K. K. H., Mata, M., et al. (2013). Antitumor effects of chimeric receptor engineered human T cells directed to tumor stroma. Mol Ther, 21, 1611\u20131620. https:\/\/doi.org\/10.1038\/mt.2013.110.","journal-title":"Mol Ther"},{"key":"9909_CR155","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1158\/2326-6066.CIR-13-0027","volume":"2","author":"L-CS Wang","year":"2014","unstructured":"Wang, L.-C. S., Lo, A., Scholler, J., et al. (2014). Targeting fibroblast activation protein in tumor stroma with chimeric antigen receptor T cells can inhibit tumor growth and augment host immunity without severe toxicity. Cancer Immunol Res, 2, 154\u2013166. https:\/\/doi.org\/10.1158\/2326-6066.CIR-13-0027.","journal-title":"Cancer Immunol Res"},{"key":"9909_CR156","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1084\/jem.20130110","volume":"210","author":"E Tran","year":"2013","unstructured":"Tran, E., Chinnasamy, D., Yu, Z., et al. (2013). Immune targeting of fibroblast activation protein triggers recognition of multipotent bone marrow stromal cells and cachexia. J Exp Med, 210, 1125\u20131135. https:\/\/doi.org\/10.1084\/jem.20130110.","journal-title":"J Exp Med"},{"key":"9909_CR157","doi-asserted-by":"publisher","first-page":"3981","DOI":"10.1158\/1078-0432.CCR-17-1788","volume":"24","author":"P Gulati","year":"2018","unstructured":"Gulati, P., Ruhl, J., Kannan, A., et al. (2018). Aberrant Lck signal via CD28 Costimulation augments antigen-specific functionality and tumor control by redirected T cells with PD-1 blockade in humanized mice. Clin Cancer Res, 24, 3981\u20133993. https:\/\/doi.org\/10.1158\/1078-0432.CCR-17-1788.","journal-title":"Clin Cancer Res"},{"key":"9909_CR158","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41586-019-1546-z","volume":"573","author":"H Aghajanian","year":"2019","unstructured":"Aghajanian, H., Kimura, T., Rurik, J. G., et al. (2019). Targeting cardiac fibrosis with engineered T cells. Nature, 573, 430\u2013433. https:\/\/doi.org\/10.1038\/s41586-019-1546-z.","journal-title":"Nature"}],"container-title":["Cancer and Metastasis Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-020-09909-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10555-020-09909-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-020-09909-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T13:49:48Z","timestamp":1684849788000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10555-020-09909-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,29]]},"references-count":158,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["9909"],"URL":"https:\/\/doi.org\/10.1007\/s10555-020-09909-3","relation":{},"ISSN":["0167-7659","1573-7233"],"issn-type":[{"value":"0167-7659","type":"print"},{"value":"1573-7233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,29]]},"assertion":[{"value":"29 June 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All other authors declare no potential conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}